skip to Main Content

A Model for Predicting the Risk of Healthy Organ Exposure in Patients With Locally Advanced Pancreatic Cancer Treated With SBRT

A Model for Predicting the Risk of Healthy Organ Exposure in Patients With Locally Advanced Pancreatic Cancer Treated With SBRT
According to the results of a study published in Radiotherapy and Oncology, a population-based model showed promise in facilitating the selection of patients with locally advanced pancreatic cancer (LAPC) at risk of exposure of healthy organs to stereotactic body radiation therapy (SBRT).

Although the tumors of patients with LAPC have not spread to distant sites, they are classified as unresectable due to local invasion of adjacent structures. Treatment options for these patients include chemotherapy, chemoradiation therapy with standard radiation therapy, and SBRT.  Read more . . . 


Back To Top